Hong. Lu, et.al., Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR., Toxicological sciences : an official journal of the Society of Toxicology, 2008, 103

http://rdf.ncbi.nlm.nih.gov/pubmed/18296417

Hong. Lu, et.al., Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR., Toxicological sciences : an official journal of the Society of Toxicology, 2008, 103

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD22923
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD22923

allele

http://purl.org/net/cito/citesAsAuthority

• Slco1b2<tm1Cdk>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3785252

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal xenobiotic pharmacokinetics_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0008875I129S1SvC57BL6Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating chloride level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0003019B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating sodium level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0005633B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• abnormal circulating protein level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0005416B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• decreased circulating amylase level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0008805B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating bilirubin level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0005344B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating cholesterol level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0005178B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• decreased sensitivity to xenobiotic induced morbidity/mortality_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0009767B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating alanine transaminase level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0002941B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• decreased physiological sensitivity to xenobiotic_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0008874I129S1SvC57BL6Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• abnormal liver physiology_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0000609I129S1SvC57BL6Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• increased circulating total protein level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0005568B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• abnormal circulating serum albumin level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0000199B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• abnormal circulating mineral level_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0006357B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• decreased physiological sensitivity to xenobiotic_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0008874B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk
• abnormal liver physiology_Slco1b2<tm1Cdk>/Slco1b2<tm1Cdk>
  http://metadb.riken.jp/0000609B6129S1Slco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1CdkSlco1b2tm1Cdk